Navigation Links
A Novel approach in Malaria treatment

A new treatment for malaria has been developed with the help of British scientists that could save several thousand of young lives in Africa. A system based on fluid// replacement for children suffering from malaria, has been developed by the Imperial College in London in collaboration with the Wellcome Trust Kenya Medical Research Institute Centre.

Approximately 80% of the lives of millions of kids, who die every year due to malaria, could be saved. 98% survival after treatment was reported in a trial of 88 children with malaria.

The treatment developed in an 8-year collaborative study is published in the journal PLOS Clinical Trials. The study revealed that fluid depletion was the major cause of occurrence of serious symptoms in Kenyan kids with malaria.

Previously, kids with severe malaria were not given extra fluids due to the fear of aggravation of brain swellings linked with the disease. The new treatment incorporates albumin, a protein that retains water inside the blood vessel, in resuscitation fluids given to children. In the two initial studies, less than 5% of the kids died who received albumin when compared to nearly 40% dying after receiving conventional treatment.

A new trial was carried out on 88 kids with severe malaria, in which, the kids were given either albumin solution or a plasma substitute called gelofusin. Though reduction in shock was seen in both the cases, only 2% of the kids who received albumin died when compared to 16% receiving gelofusion.

Researcher Dr Kathryn Maitland said: "The observation that treating very sick children with severe malaria with albumin infusion can reduce the mortality rate by over 80%, represents a major breakthrough towards improved treatment of this devastating illness.

"However, administration of fluid to children critically ill with malaria is contrary to prevailing practice, and albumin is currently not available in most African hospitals.
"It is absolutely essential that the results are reproduced in larger studies before we advise on any change in practice."

"The results of this trial support have gone some way to answering the question of whether this sort of supportive treatment saves lives and we are now seeking funding to set up a larger trial involving over 1,000 children in Ghana, Gambia and Kenya to confirm these findings," Maitland said.

Professor Brian Greenwood, of the London School of Hygiene and Tropical Medicine, said: "There was still much confusion about whether or not to give children with malaria fluids. The numbers in the trial are small, but this is an encouraging result which certainly should be followed up."
GYT
'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... , ... March 28, 2017 ... ... non-profit medical society dedicated to advancing the science and clinical practice of ... its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a leading ... Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up ... association with efforts by the American College of Surgeons, U.S. Department of Defense, ...
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... director. Mr. Still was selected through a careful months-long search by the RBMA Board ... to our members, has been a part of building the RBMA since 1992,” said ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm ... its corporate headquarters to a new, more expansive office space in order to ... Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 Silas ...
(Date:3/28/2017)... Billerica, MA (PRWEB) , ... March 28, 2017 ... ... instrument for direct measurement of corrosive ions found in power plant water and ... plant components such as turbines and boilers, leading to extensive maintenance and unplanned ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... -- The global surgical sealants and ... USD 4.5 billion by 2025, according to a new ... injured tissues post operation is a major step to ... 3% to 15% of cases and are considered as ... of postoperative deaths in patients. Surgical sealants and adhesives ...
(Date:3/27/2017)... -- Summary This report provides all ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/27/2017)... -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the "Company") ... common stock in an underwritten public offering under an ... and Exchange Commission (the "SEC"). The offering is subject ... no assurance as to whether or when the offering ... or terms of the offering. Cryoport also expects to ...
Breaking Medicine Technology: